{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:06:26Z","timestamp":1781222786900,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54AA027989"],"award-info":[{"award-number":["U54AA027989"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001863"],"award-info":[{"award-number":["UL1TR001863"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK112771"],"award-info":[{"award-number":["R01DK112771"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK115893"],"award-info":[{"award-number":["K23DK115893"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dadr.2026.100428","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:37:20Z","timestamp":1773189440000},"page":"100428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Naltrexone\/bupropion for binge-eating disorder: A human laboratory investigation of mechanisms"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8185-9201","authenticated-orcid":false,"given":"Sherry A.","family":"McKee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Lydecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Pittman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania M.","family":"Jastreboff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph J.","family":"DiLeone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meaghan","family":"Lavery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Grilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2026.100428_bib1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https:\/\/doi.org\/10.1176\/appi.books.9780890425596.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"10.1016\/j.dadr.2026.100428_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.04.004","article-title":"Naltrexone\/bupropion for obesity: an investigational combination pharmacotherapy for weight loss","volume":"84","author":"Billes","year":"2014","journal-title":"Pharm. Res"},{"key":"10.1016\/j.dadr.2026.100428_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0376-8716(93)90061-T","article-title":"The economic context of drug and non-drug reinforcers affects acquisition and maintenance of drug-reinforced behavior and withdrawal effects","volume":"33","author":"Carroll","year":"1993","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2026.100428_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/ijo.2017.89","article-title":"Early improvement in food cravings are associated with long-term weight loss success in a large clinical sample","author":"Dalton","year":"2017","journal-title":"Int J. Obes. (Lond. )"},{"key":"10.1016\/j.dadr.2026.100428_bib5","first-page":"3711","article-title":"Sweet taste pleasantness is modulated by morphine and naltrexone","volume":"233","author":"Eikemo","year":"2016"},{"key":"10.1016\/j.dadr.2026.100428_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/oby.23790","article-title":"Behavioral weight loss outcomes in individuals with binge-eating disorder: a meta-analysis","volume":"31","author":"Forman","year":"2023","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.dadr.2026.100428_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10640266.2014.931763","article-title":"Determining empirical thresholds for \"definitely large\" amounts of food for defining binge-eating episodes","volume":"23","author":"Forney","year":"2015","journal-title":"Eat. Disord."},{"issue":"10","key":"10.1016\/j.dadr.2026.100428_bib8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamapsychiatry.2016.2157","article-title":"Association of the sweet-liking phenotype and craving for alcohol with the response to naltrexone treatment in alcohol dependence: a randomized clinical trial","volume":"73","author":"Garbutt","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.dadr.2026.100428_bib9","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1210\/jc.2009-1350","article-title":"Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo","volume":"94","author":"Greenway","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.dadr.2026.100428_bib10","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(10)60888-4","article-title":"Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multi-centre randomized double-blind placebo-controlled phase 3 trial","volume":"376","author":"Greenway","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.dadr.2026.100428_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-clinpsy-080822-043256","article-title":"Treatment of eating disorders: current status, challenges, and future directions","volume":"20","author":"Grilo","year":"2024","journal-title":"Annu Rev. Clin. Psychol."},{"key":"10.1016\/j.dadr.2026.100428_bib12","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.20220267","article-title":"Naltrexone plus bupropion combination medication and behavior therapy, alone and combined, for binge-eating disorder: randomized double-blind placebo-controlled trial","volume":"179","author":"Grilo","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.dadr.2026.100428_bib13","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1017\/S0033291723001800","article-title":"Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial","volume":"53","author":"Grilo","year":"2023","journal-title":"Psychol. Med"},{"issue":"11","key":"10.1016\/j.dadr.2026.100428_bib14","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/oby.23898","article-title":"Naltrexone\/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial","volume":"31","author":"Grilo","year":"2023","journal-title":"Obes. (Silver Spring)"},{"issue":"10","key":"10.1016\/j.dadr.2026.100428_bib15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/oby.2002.139","article-title":"Binge size increases with body mass index in women with binge-eating disorder","volume":"10","author":"Guss","year":"2002","journal-title":"Obes. Res"},{"issue":"3","key":"10.1016\/j.dadr.2026.100428_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(96)00446-7","article-title":"The influence of alternative reinforcers on cocaine use and abuse: a brief review","volume":"57","author":"Higgins","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.dadr.2026.100428_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2337\/dc12-1112","article-title":"Neural correlates of stress- and food cue-induced food craving in obesity: association with insulin levels","volume":"36","author":"Jastreboff","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.dadr.2026.100428_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104726","article-title":"Role of the striatal dopamine, GABA and opioid systems in mediating feeding and fat intake","volume":"139","author":"Joshi","year":"2022","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.dadr.2026.100428_bib19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.biopsych.2012.11.020","article-title":"The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys","volume":"73","author":"Kessler","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.dadr.2026.100428_bib20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/alcalc\/agq101","article-title":"Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference","volume":"46","author":"Laaksonen","year":"2011","journal-title":"Alcohol Alcohol"},{"issue":"6","key":"10.1016\/j.dadr.2026.100428_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/eat.20648","article-title":"Stress-induced laboratory eating behavior in obese women with binge eating disorder","volume":"42","author":"Laessle","year":"2009","journal-title":"Int J. Eat. Disord."},{"issue":"2","key":"10.1016\/j.dadr.2026.100428_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0195-6663(90)90002-P","article-title":"A behavioral economics analysis of food choice in humans","volume":"14","author":"Lappalainen","year":"1990","journal-title":"Appetite"},{"issue":"1","key":"10.1016\/j.dadr.2026.100428_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13098-024-01319-7","article-title":"The effects of bupropion alone and combined with naltrexone on weight loss: a systematic review and meta-regression analysis of randomized controlled trials","volume":"16","author":"Liu","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.dadr.2026.100428_bib24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4088\/JCP.sh16003su1c.03","article-title":"Pharmacologic treatments for binge-eating disorder","volume":"78S1","author":"McElroy","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"11","key":"10.1016\/j.dadr.2026.100428_bib25","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ntr\/nts090","article-title":"Developing and validating a human laboratory model to screen medications for smoking cessation","volume":"14","author":"McKee","year":"2012","journal-title":"Nicotine Tob. Res"},{"issue":"1","key":"10.1016\/j.dadr.2026.100428_bib26","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41467-018-03848-y","article-title":"\u03bc-opioid receptor system mediates reward processing in humans","volume":"9","author":"Nummenmaa","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.dadr.2026.100428_bib27","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1037\/h0077714","article-title":"A circumplex model of affect","volume":"39","author":"Russell","year":"1980","journal-title":"J. Personal. Soc. Psychol."},{"key":"10.1016\/j.dadr.2026.100428_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/scan\/nsw049","article-title":"Neural signature of food reward processing in bulimic-type eating disorders","author":"Simon","year":"2016","journal-title":"Soc. Cogn. Affect Neurosci."},{"key":"10.1016\/j.dadr.2026.100428_bib29","series-title":"Bupropion and naltrexone interact synergistically to decrease food intake in mice Presented at the North American association for the study of obesity annual scientific meeting","author":"Sinnayah","year":"2007"},{"issue":"5","key":"10.1016\/j.dadr.2026.100428_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2018.03.014","article-title":"Prevalence and Correlates of DSM-5-Defined Eating Disorders in a Nationally Representative Sample of U.S. Adults","volume":"84","author":"Udo","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.dadr.2026.100428_bib31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/eat.23004","article-title":"Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States","volume":"52","author":"Udo","year":"2019","journal-title":"Int J. Eat. Disord."},{"issue":"1","key":"10.1016\/j.dadr.2026.100428_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.eatbeh.2012.10.010","article-title":"Modeling the effects of positive and negative mood on the ability to resist eating in obese and non-obese individuals","volume":"14","author":"Udo","year":"2013","journal-title":"Eat. Behav."},{"issue":"1","key":"10.1016\/j.dadr.2026.100428_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tics.2010.11.001","article-title":"Reward, dopamine and the control of food intake: implications for obesity","volume":"15","author":"Volkow","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.dadr.2026.100428_bib34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/oby.2010.147","article-title":"Weight loss with naltrexone SR\/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial","volume":"19","author":"Wadden","year":"2011","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.dadr.2026.100428_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ijo.2013.145","article-title":"Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues","volume":"38","author":"Wang","year":"2014","journal-title":"Int J. Obes. (Lond. )"},{"key":"10.1016\/j.dadr.2026.100428_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.786358","article-title":"Delay Discounting in Established and Proposed Behavioral Addictions: A Systematic Review and Meta-Analysis","volume":"15","author":"Weinsztok","year":"2021","journal-title":"Front Behav. Neurosci."},{"key":"10.1016\/j.dadr.2026.100428_bib37","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.2015.1617","article-title":"Naltrexone extended-release plus bupropion extended-release for treatment of obesity","volume":"313","author":"Yanovski","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.dadr.2026.100428_bib38","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0031-9384(96)80017-5","article-title":"Selective effects of naltrexone on food pleasantness and intake","volume":"60","author":"Yeomans","year":"1996","journal-title":"Physiol. Behav."}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724626000211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724626000211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:44:28Z","timestamp":1781221468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724626000211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":38,"alternative-id":["S2772724626000211"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100428","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naltrexone\/bupropion for binge-eating disorder: A human laboratory investigation of mechanisms","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2026.100428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100428"}}